Skip to content

Attitudes and Beliefs about the Therapeutic Use of Psychedelic Drugs among Psychologists in the United States

Alan K. Davis, Gabrielle Agin-Liebes, Megan España, Brian Pilecki, Jason B. Luoma

Journal of Psychoactive Drugs September 1, 2021 DOI: 10.1080/02791072.2021.1971343 (opens in new tab)

Study at a glance

AI-extracted from the abstract
Characteristics Cross-sectional quasi-experimental electronic survey Peer reviewed
Sample size 366
Population Clinical psychologists in the United States
Citations 103
Key findings Clinical psychologists have cautiously favorable attitudes toward psychedelic-assisted therapy but express concerns about risks and a need for more education and training.

Abstract

Psychologists are a vital component of mental health treatment and their perceptions of psychedelic-assisted therapy are critical for future implementation. This cross-sectional quasi-experimental electronic survey study explored the attitudes about psychedelics used in treatment among 366 clinical psychologists in the United States. Participants expressed cautiously favorable attitudes toward therapeutic psychedelic experiences but indicated concern about possible psychiatric and neurocognitive risks. Most participants indicated that they lack an understanding of the full range of effects of psychedelics, would need to seek out additional consultation, and endorsed positive beliefs in the potential of psychedelic treatment and the need for further research. Overall, this research identified the need to increase education and training about psychedelics for psychologists in order to help increase knowledge and reduce stigma about psychedelic therapies.

Citations in the library

Cited by 91

and 86 more in the library

Cites 30

and 25 more in the library

Explore topics